X4P-001

· X4 Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for X4P-001, covering 2021-11-02 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]